<?xml version="1.0" encoding="UTF-8"?>
<p>Results of various treatments groups on body weight of diabetic rats are presented in 
 <xref ref-type="fig" rid="molecules-26-00137-f002">Figure 2</xref>C,D. There was no significant effect on body weight of diabetic rats on days 1 and 5. However, the weight of diabetic control rats (group II) was significantly decreased on day 15 (
 <italic>p</italic> &lt; 0.001) and 21 (
 <italic>p</italic> &lt; 0.001) in comparison to the normal saline control rats (group I). Diabetic rats treated with glibenclamide (5 mg/kg, p.o) has significantly (
 <italic>p</italic> &lt; 0.001) reversed diabetes-induced decrease in body weight on day 15 and 21 compared to diabetic control rats. Moreover, diabetic rats treated with CTN (15, 30 and 50 mg/kg, p.o) reversed the STZ mediated reduction in body weight and significantly increased the body weight on day 15 (
 <italic>p</italic> &lt; 0.001) followed by day 21 (
 <italic>p</italic> &lt; 0.001) when compared to diabetic control rats.
</p>
